200 ML ropivacaine hydrochloride 2 MG/ML Injection [Naropin]
RxNorm concept 1734356, branded drug (sbd). Prescribable name: Naropin 0.2 % in 200 ML Injection.
- RxCUI
- 1734356
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1734356 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
200 ML Naropin 2 MG/ML Injection; 200 ML ROPivacaine hydrochloride 2 MG/ML Injection [Naropin]; Naropin 0.2 % per 200 ML Injection; Naropin 400 MG per 200 ML Injection
Related concepts
- ropivacaine hydrochloride 2 MG/ML (SCDC, consists of)
- ropivacaine hydrochloride 2 MG/ML [Naropin] (SBDC, consists of)
- Injection (DF, has dose form)
- Naropin (BN, has ingredient)
- 200 ML ropivacaine hydrochloride 2 MG/ML Injection (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1734356 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1734356 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1734356. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.